Blueprint Medicines' Leadership in Driving Continued Innovation in Systemic Mastocytosis Highlighted at 2023 ASH Annual Meeting
/PRNewswire/ -- Blueprint Medicines Corporation (Nasdaq: BPMC) today announced data showcasing its commitment to advance the scientific understanding and...
San Diego Convention Center United States United Kingdom San Diego Becker Hewes European Medicines Agency
Source: prnewswire.com